![]() |
市場調查報告書
商品編碼
1746834
日本血栓切除設備市場報告(按產品類型、應用、最終用戶和地區)2025 年至 2033 年Japan Thrombectomy Devices Market Report by Product Type, Application, End User, and Region 2025-2033 |
2024年,日本血栓切除設備市場規模達5,390萬美元。展望未來, IMARC Group預計到2033年,該市場規模將達到9,570萬美元,2025-2033年期間的複合年成長率(CAGR)為6.27%。人口結構變化、技術進步以及對微創醫療的重視是推動市場發展的關鍵因素。
血栓切除裝置在替代終點方面具有一系列優勢,包括生物標記分析、梗塞面積縮小、ST 段回撤改善以及心肌梗塞血管造影溶栓 (TIMI) 血流增強等。這些裝置旨在最大限度地減少失血量,並最大程度地減少醫療操作過程中對血管壁的損傷。因此,它們可用於治療靜脈、動脈和毛細血管內的血栓。此外,它們還可用於治療肺栓塞和周邊動脈疾病等疾病。目前,血栓切除裝置有各種尺寸和直徑,可根據特定治療區域進行客製化。最常用的血栓切除術包括球囊栓塞切除術、手術栓塞切除術和抽吸栓塞切除術。
日本血栓切除器械市場正經歷顯著成長,這主要得益於幾個關鍵因素。其中一個主要促進因素是老年人口中血管疾病(包括周邊動脈疾病和靜脈血栓栓塞症)的盛行率不斷上升。隨著日本老齡人口不斷成長,對有效的血栓切除手術和器械的需求也日益成長。此外,日本的醫療保健領域也非常重視微創手術。血栓切除器械能夠以微創的方式處理血栓和阻塞,與此趨勢完美契合。越來越多的患者和醫護人員選擇能夠最大程度減少創傷、縮短住院時間和加速康復的手術,這進一步推動了血栓切除器械的普及。日本先進的醫療基礎設施和技術實力也在血栓切除器械市場的成長中發揮關鍵作用。該國在醫學研究和創新方面處於領先地位,引領先進血栓切除術技術的發展。此外,醫護人員和患者對及時進行血栓切除術的益處(例如降低發病率和改善生活品質)的認知不斷提高,這有望在未來幾年持續成長。
市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭指標和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。
Japan thrombectomy devices market size reached USD 53.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 95.7 Million by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. Demographic shifts, technological advancements, and a commitment to minimally invasive healthcare represent some of the key factors driving the market.
Thrombectomy devices offer a range of advantages when it comes to surrogate endpoints, encompassing factors like biomarker analysis, reduction in infarct size, improved ST-segment resolution, and enhanced angiographic thrombolysis in myocardial infarction (TIMI) flow. These devices are designed to minimize blood loss and minimize damage to the vessel wall during medical procedures. As a result, they have applications in the treatment of blood clots within veins, arteries, and capillaries. Additionally, they are employed in addressing conditions such as pulmonary embolism and peripheral arterial diseases. Thrombectomy devices are currently available in various sizes and diameters, tailored to the specific area requiring treatment. Among the most commonly utilized thrombectomy procedures are balloon embolectomy, surgical embolectomy, and aspiration embolectomy.
The thrombectomy devices market in Japan is experiencing notable growth, driven by several key factors. One of the primary drivers is the increasing prevalence of vascular diseases, including peripheral arterial diseases and venous thromboembolism, within the aging population. As Japan grapples with a growing elderly demographic, the demand for effective thrombectomy procedures and devices is on the rise. Furthermore, there is a significant emphasis on minimally invasive procedures in the country's healthcare landscape. Thrombectomy devices, with their ability to address blood clots and blockages in a less invasive manner, align perfectly with this trend. Patients and healthcare professionals alike are increasingly opting for procedures that minimize trauma, reduce hospital stays, and expedite recovery, further boosting the adoption of thrombectomy devices. Japan's advanced healthcare infrastructure and technological prowess also play a pivotal role in the growth of the thrombectomy devices market. The country is at the forefront of medical research and innovation, leading to the development of advanced thrombectomy technologies. Additionally, increasing awareness among both healthcare providers and patients about the benefits of timely thrombectomy procedures, such as reduced morbidity and improved quality of life, is poised for continued growth in the coming years.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.